Continuous Glucose Monitoring System Market Research Report Forecast till 2032
Market Report I 2024-04-30 I 152 Pages I Market Research Future
Continuous Glucose Monitoring System Market Research Report Forecast till 2032
Download PDF
Market Overview
Continuous Glucose Monitoring System Market is projected to register a CAGR of 11.24% during the review period.
The rising pervasiveness of diabetes overall stands apart as a conspicuous driver energizing the development of the worldwide continuous glucose monitoring systems market. Diabetes has arrived at plague extents, with a stunning ascent in the quantity of impacted people universally. As per the Global Diabetes Alliance (IDF), in 2021, roughly 537 million individuals overall were living with diabetes, and this number is supposed to take off to 643 million by 2030. Essentially, as per the American Diabetes Affiliation, diabetes impacted 38.4 million Americans, or 11.6% of the populace, in 2021. Type 1 diabetes influences around 2.0 million Americans, including roughly 304,000 youngsters and teenagers. The heightening rate of diabetes is ascribed to different elements, including stationary ways of life, unfortunate dietary propensities, and the maturing populace. As the diabetic populace keeps on developing, the interest for powerful diabetes the board arrangements turn out to be really squeezing. Continuous glucose monitoring systems assume a vital part in giving constant experiences into blood glucose levels, empowering patients and medical care experts to settle on convenient and informed choices in regard to therapy and way of life changes. The capacity of continuous glucose monitoring systems to offer continuous monitoring, early discovery of variances, and customized bits of knowledge lines up with the developing requirements of the extending diabetic populace.
Market Segmentation
Based on product the continuous glucose monitoring system market is divided into sensors and transmitter and receivers.
In terms of application, the market is classified into type 2 diabetes, type 1 diabetes, and non-diabetic patients.
Based on End user, the market has been divided into hospitals & clinics, homecare settings, and others.
Regional Insights
The North America continuous glucose monitoring systems market represented USD 3.07 billion out of 2023 and is projected to develop at a CAGR of 10.06% during the figure time frame. North America is additionally fragmented into the US, and Canada.
The North America continuous glucose monitoring systems market is encountering strong development, driven by mechanical progressions and a rising predominance of diabetes in the region.
Europe continuous glucose monitoring System market represented the second-biggest market share because of innovation progressions, expanding medical care consumption, and expanding pervasiveness of diabetes.
The Asia-Pacific Continuous Glucose Monitoring System market is supposed to be the quickest developing from 2023 to 2030 attributable to high persistent populace, decreased expenses of leading preliminaries, and good administrative arrangements. In addition, central participants working in the Continuous Glucose Monitoring System Market are effectively venturing into this region, further driving the regional market development.
Major Players
Key Companies operating in the Continuous Glucose Monitoring System market are Dexcom, Inc (US), Menarini Diagnostics Srl (Italy), Senseonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc (US), Ultrahuman Healthcare Pvt Ltd (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), and Sinocare (China).
TABLE OF CONTENTS
1 MARKET INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF THE STUDY
1.3 RESEARCH OBJECTIVE
1.4 MARKET STRUCTURE
2 RESEARCH METHODOLOGY
2.1 OVERVIEW
2.2 DATA FLOW
2.2.1 DATA MINING PROCESS
2.3 PURCHASED DATABASE
2.4 SECONDARY SOURCES
2.4.1 SECONDARY RESEARCH DATA FLOW:
2.5 PRIMARY RESEARCH:
2.5.1 PRIMARY RESEARCH DATA FLOW:
2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
2.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
2.6.1 REVENUE ANALYSIS APPROACH
2.7 DATA FORECASTING
2.7.1 DATA FORECASTING TECHNIQUE
2.8 DATA MODELING
2.8.1 MICROECONOMIC FACTOR ANALYSIS:
2.8.2 DATA MODELING:
2.9 TEAMS AND ANALYST CONTRIBUTION
3 MARKET DYNAMICS
3.1 INTRODUCTION
3.2 DRIVERS
3.2.1 INCREASING PREVALENCE OF DIABETES
3.2.2 RISING AWARENESS AMONG INDIVIDUALS ABOUT THE BENEFITS OF CONTINUOUS GLUCOSE MONITORING AND PATIENT EDUCATION
3.2.3 INCREASING GERIATRIC POPULATION
3.3 RESTRAINTS
3.3.1 HIGH COST OF CONTINUOUS GLUCOSE MONITORING SYSTEMS
3.4 OPPORTUNITY
3.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION
4 MARKET FACTOR ANALYSIS
4.1 VALUE CHAIN ANALYSIS
4.1.1 R&D
4.1.2 MANUFACTURING
4.1.3 DISTRIBUTION AND SALES
4.1.4 POST-SALES MONITORING
4.2 PORTER'S FIVE FORCES MODEL
4.2.1 THREAT OF NEW ENTRANTS
4.2.2 BARGAINING POWER OF SUPPLIERS
4.2.3 THREAT OF SUBSTITUTES
4.2.4 BARGAINING POWER OF BUYERS
4.2.5 INTENSITY OF RIVALRY
4.3 IMPACT OF COVID-19 ON THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS
MARKET
4.3.1 OVERVIEW
5 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 SENSORS
5.3 TRANSMITTER & RECEIVERS
6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 TYPE 2 DIABETES
6.3 TYPE 1 DIABETES
6.4 NON-DIABETIC PATIENTS
6.4.1 WEIGHT LOSS
6.4.2 DIET MANAGEMENT
6.4.3 HEALTH & WELLNESS
7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS & CLINICS
7.3 HOMECARE SETTINGS
7.4 OTHERS
8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION
8.1 GLOBAL
8.2 NORTH AMERICA
8.2.1 US
8.2.2 CANADA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 UK
8.3.4 ITALY
8.3.5 SPAIN
8.3.6 REST OF EUROPE
8.4 ASIA-PACIFIC
8.4.1 CHINA
8.4.2 INDIA
8.4.3 JAPAN
8.4.4 SOUTH KOREA
8.4.5 AUSTRALIA
8.4.6 REST OF ASIA-PACIFIC
8.5 REST OF THE WORLD
8.5.1 MIDDLE EAST & AFRICA
8.5.2 LATIN AMERICA
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS, 2023
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
9.6.2 AGREEMENT
9.6.3 PARTNERSHIP
9.6.4 COLLABORATION
10 COMPANY PROFILES
10.1 DEXCOM, INC
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 A. MENARINI DIAGNOSTICS SRL
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIES
10.3 SENSEONICS
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIES
10.4 MEDTRUM TECHNOLOGIES INC.
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIES
10.5 NEMAURA MEDICAL INC
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 KEY STRATEGIES
10.6 ULTRAHUMAN HEALTHCARE PVT LTD
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL OVERVIEW
10.6.3 PRODUCTS OFFERED
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIES
10.7 MEDTRONIC
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.7.6 KEY STRATEGIES
10.8 ONE DROP
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 KEY STRATEGIES
10.9 ABBOTT LABORATORIES, INC
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.9.6 KEY STRATEGIES
10.10 SINOCARE
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIES
10.11 NUTRISENSE
10.11.1 COMPANY OVERVIEW
10.11.2 FINANCIAL OVERVIEW
10.11.3 PRODUCTS OFFERED
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIES
10.12 SUPERSAPIENS
10.12.1 COMPANY OVERVIEW
10.12.2 FINANCIAL OVERVIEW
10.12.3 PRODUCTS OFFERED
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIES
10.13 SIGNOS INC.
10.13.1 COMPANY OVERVIEW
10.13.2 FINANCIAL OVERVIEW
10.13.3 PRODUCTS OFFERED
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIES
10.14 LEVELS
10.14.1 COMPANY OVERVIEW
10.14.2 FINANCIAL OVERVIEW
10.14.3 PRODUCTS OFFERED
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIES
10.15 VERI
10.15.1 COMPANY OVERVIEW
10.15.2 FINANCIAL OVERVIEW
10.15.3 PRODUCTS OFFERED
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIES
10.16 LUMEN
10.16.1 COMPANY OVERVIEW
10.16.2 FINANCIAL OVERVIEW
10.16.3 PRODUCTS OFFERED
10.16.4 KEY DEVELOPMENTS
10.16.5 KEY STRATEGIES
10.17 JANUARY.AI
10.17.1 COMPANY OVERVIEW
10.17.2 FINANCIAL OVERVIEW
10.17.3 PRODUCTS OFFERED
10.17.4 KEY DEVELOPMENTS
10.17.5 KEY STRATEGIES
11 DATA CITATIONS
LIST OF TABLES
TABLE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTER & RECEIVERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD BILLION)
TABLE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY REGION, 2019-2032 (USD BILLION)
TABLE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR WEIGHT LOSS, BY REGION, 2019-2032 (USD BILLION)
TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIET MANAGEMENT, BY REGION, 2019-2032 (USD BILLION)
TABLE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET HEALTH & WELLNESS, BY REGION, 2019-2032 (USD BILLION)
TABLE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD BILLION)
TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOMECARE SETTINGS, BY REGION, 2019-2032 (USD BILLION)
TABLE 15 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 16 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD BILLION)
TABLE 17 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 18 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 19 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 20 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 21 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 22 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 23 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 24 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 25 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 26 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 27 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 28 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 29 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 30 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 31 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 32 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 34 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 35 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 36 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 37 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 38 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 39 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 40 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 41 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 42 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 43 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 44 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 45 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 46 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 47 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 48 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 49 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 50 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 51 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 52 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 53 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 54 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 55 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 56 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 57 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 58 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 59 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 60 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 61 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 62 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 63 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 64 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 65 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 66 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 67 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 68 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 69 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 70 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 71 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 72 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 73 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 74 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 75 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 76 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 77 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 78 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 79 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 80 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 81 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 82 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 83 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 84 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 85 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 86 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 87 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 88 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD BILLION)
TABLE 89 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 90 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 91 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 92 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 93 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 94 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 95 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 96 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 97 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 98 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 99 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 100 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
TABLE 101 PUBLIC PLAYERS STOCK SUMMARY
TABLE 102 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 103 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 104 AGREEMENT
TABLE 105 PERTNERSHIP
TABLE 106 COLLABORATION
TABLE 107 DEXCOM, INC: PRODUCT OFFERED
TABLE 108 DEXCOM, INC: KEY DEVELOPMENTS
TABLE 109 A. MENARINI DIAGNOSTICS SRL: PRODUCT OFFERED
TABLE 110 A. MENARINI DIAGNOSTICS SRL: KEY DEVELOPMENTS
TABLE 111 SENSEONICS: PRODUCT OFFERED
TABLE 112 SENSEONICS: KEY DEVELOPMENTS
TABLE 113 MEDTRUM TECHNOLOGIES INC.: PRODUCTS OFFERED
TABLE 114 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 115 NEMAURA MEDICAL INC.: KEY DEVELOPMENTS
TABLE 116 ULTRAHUMAN HEALTHCARE PVT LTD.: PRODCUTS OFFERED
TABLE 117 MEDTRONIC: PRODUCTS OFFERED
TABLE 118 MEDTRONIC: KEY DEVELOPMENTS
TABLE 119 ONE DROP: PRODUCTS OFFERED
TABLE 120 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 121 ABBOTT LABORATORIES, INC.: KEY DEVELOPMENTS
TABLE 122 SINOCARE: PRODUCTS OFFERED
TABLE 123 NUTRISENSE: PRODUCTS OFFERED
TABLE 124 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 125 SIGNOS INC.: PRODUCTS OFFERED
TABLE 126 LEVELS: PRODUCTS OFFERED
TABLE 127 VERI: PRODUCTS OFFERED
TABLE 128 LUMEN: PRODUCTS OFFERED
TABLE 129 JANUARY.AI: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: STRUCTURE
FIGURE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
FIGURE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY END USER, 2023
FIGURE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY REGION, 2023 (% SHARE)
FIGURE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 15 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 16 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 17 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 18 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 20 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 21 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 22 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY REGION, 2023
FIGURE 23 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET PLAYERS: COMPETITIVE ANALSIS, 2023
FIGURE 24 COMPETITOR DASHBOARD: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 25 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 DEXCOM, INC: SWOT ANALYSIS
FIGURE 27 SENSEONICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 NEMAURA MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 NEMAURA MEDICAL INC.: SWOT ANALYSIS
FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 MEDTRONIC: SWOT ANALYSIS
FIGURE 32 ONE DROP: SWOT ANALYSIS
FIGURE 33 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ABBOTT LABORATORIES INC.: SWOT ANALYSIS
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.